Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer by Martin Stockler, Yu Yang Soon, Chee Khoon Lee, Teng Hwee Tan

“…BMJ Oncology…”
Get full text

Prospective evaluation of artificial intelligence (AI) applications for use in cancer pathways following diagnosis: a systematic review by Ajay Aggarwal, Richard Sullivan, Andrew Hope, Peng Yun Ng, Sheba Macheka

“…BMJ Oncology…”
Get full text

Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival? by Hester F Lingsma, David van Klaveren, Arjan A van de Loosdrecht, Anna van Rhenen, Otto Visser, Valery E P P Lemmens, Nikki van Leeuwen, Gerwin Huls, Z L Rana Kaplan, Eduardus F M Posthuma, Danielle van Lammeren-Venema, Tjeerd J F Snijders, Catharina H M J van Elssen, Peter A von dem Borne, Nicole M A Blijlevens, Jan J Cornelissen, Marc H G P Raaijmakers, Avinash G Dinmohamed

“…BMJ Oncology…”
Get full text

Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy by Jie Yang, Jian-Guo Zhou, Benjamin Frey, Hu Ma, Haitao Wang, Markus Hecht, Rainer Fietkau, Udo Gaipl, Xiaofei Chen, Ada Hang-Heng Wong, Fangya Tan, Si-Si He, Gang Shen, Yun-Jia Wang, Wenzhao Zhong

“…BMJ Oncology…”
Get full text

Does the regional use of intensive chemotherapy impact the outcome of adults with AML? by Corentin Orvain

“…BMJ Oncology…”
Get full text

Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials by Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Ethan B Ludmir, Alexander D Sherry, Timothy A Lin, Esther J Beck, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Eugene J Koay, Clifton David Fuller, Charles R Thomas, Zachary R McCaw

“…BMJ Oncology…”
Get full text

Potential of neutrophil-to-eosinophil ratio as a new prognostic tool for patients with advanced renal cell carcinoma receiving first-line immuno-oncology combinations by Daniel Y C Heng, Kosuke Takemura

“…BMJ Oncology…”
Get full text

First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours by Michael Smith, Aung Naing, Todd Bauer, Kyriakos P Papadopoulos, Osama Rahma, Elena Garralda, Glenn J Hanna, Michael J Pishvaian, Xuejun Chen, Sven Gogov, Omar Saavedra, Howard Kallender, LuLu Cheng, Emil Kuriakose

“…BMJ Oncology…”
Get full text

Blood-based DNA methylation markers for lung cancer prediction by Marc Chadeau-Hyam, Paolo Vineis, Caroline Relton, Mattias Johansson, Gianluca Severi, Roger L Milne, Melissa C Southey, Pierre-Antoine Dugué, Florence Guida, Mikael Johansson, Torkjel Sandanger, Justina Ucheojor Onwuka, Ryan Langdon, Therese Haugdahl Nøst, Hilary A. Robbins, Matthew Suderman

“…BMJ Oncology…”
Get full text

Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma by Abdul Rafeh Naqash, April K Salama, Emil Lou, Andrew Elliott, Wafik S El-Deiry, Chul Kim, Stephen V Liu, Anwaar Saeed, Hirva Mamdani, Khalil Choucair, Dipesh Uprety, Phillip Walker, Himisha Beltran, Matthew James Oberley, Azhar Saeed, Lujia Chen

“…BMJ Oncology…”
Get full text

Feasibility of implementing a rapid-learning methodology to inform radiotherapy treatments: key professional stakeholders’ views by Corinne Faivre-Finn, Kevin Franks, Fiona McDonald, David P French, Daniel Johnson, Arbaz Kapadi, Gareth Price, Rebecca Holley, Kate Wicks, Kathryn Banfill, Gareth Webster

“…BMJ Oncology…”
Get full text

Uncovering the role of mismatch repair deficiency and microsatellite instability in urothelial carcinoma by Filippo Pietrantonio, Filippo Ghelardi, Patrizia Giannatempo

“…BMJ Oncology…”
Get full text

Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy by Peng Li, Haydn Kissick, Rebecca C Obeng, Tahseen H Nasti, Christiane S Eberhardt, Rafi Ahmed, Zhengjia Chen, Warren J Leonard, Suresh S Ramalingam, Andreas Wieland, Annapaola Mariniello, Jeffrey M Switchenko, Kylee Martens, Daniel Y Chang, Donald McGuire, Candace Daugherty, Yuzi Zhang, Rathi Pillai, Alice O Kamphorst

“…BMJ Oncology…”
Get full text

Novel proteomics-based plasma test for early detection of multiple cancers in the general population by Ashkan Afshin, Mohammad H Forouzanfar, Bogdan Budnik, Hossein Amirkhani

“…BMJ Oncology…”
Get full text

Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective by Alberto A Gabizon, Shira Gabizon-Peretz, Shadan Modaresahmadi, Ninh M La-Beck

“…BMJ Oncology…”
Get full text

Addressing the hidden toxicities of cancer: a call to action for clinicians, researchers and clinical trialists by Rick Bangs

“…BMJ Oncology…”
Get full text

Artificial intelligence across oncology specialties: current applications and emerging tools by Frank Lin, Tim Rattay, John Kang, Evangelia Katsoulakis, Kyle Lafata, Ellen Kim, Christopher Yao, Harsha Nori, Christoph Ilsuk Lee

“…BMJ Oncology…”
Get full text

Careful take-off by the EQ-5D-5L tool in lung cancer: fly little one, fly! by Kurt G Tournoy

“…BMJ Oncology…”
Get full text

Health-related quality of life outcomes reporting associated with FDA approvals in haematology and oncology by Bishal Gyawali, Pallawi Torka, Kristopher Attwood, Medhavi Gupta, Othman Salim Akhtar, Bhavyaa Bahl, Angel Mier-Hicks, Kayla Catalfamo

“…BMJ Oncology…”
Get full text

Advancing cancer care through digital access in the USA: a state-of-the-art review of patient portals in oncology by Liz Salmi, Jessica Ancker, Lisa Diamond, Uday Suresh, Trent Rosenbloom, Bryan Steitz

“…BMJ Oncology…”
Get full text